Program Overview

Pulmonary arterial hypertension (PAH), an incurable disease, is characterized by medial hypertrophy, intimal fibrosis, and
in situ thrombi in small muscular pulmonary arteries. PAH was considered a rapidly fatal illness with a median survival of 2.8 years in the 1980s when no evidencebased therapies were available. Since then the treatment of this disease has made tremendous advances, and in the last 10 years the discovery of new medications have positively influenced the prognosis and survival of patients with PAH.

This self-study activity is based on 3 articles that review the state of the art in lung transplantation in PAH patients.

This activity is jointly sponsored by the University of Michigan Medical School and the Pulmonary Hypertension Association.

Target Audience

This self-study activity is appropriate for cardiologists, pulmonologists, rheumatologists, and other physicians who treat patients with pulmonary hypertension.

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Discuss the factors related to timely referral of PAH patients to a lung transplant center
2. Discuss medical complications of PAH patients post lung transplantation
3. Understand the post-transplant course following lung transplantation in PAH patients

Self-Assessment Examination

1. View the entire articles.
2. Complete the online posttest and evaluation.
3. Complete the electronic credit request and activity evaluation. An electronic certificate of participation will be provided immediately.
4. Print the certificate of participation for your personal records.

Faculty

Chair

Deborah Jo Levine, MD
Director of Pulmonary Hypertension Center
University of Texas Health Science Center at San Antonio, San Antonio, Texas

Contributing Authors

Edward Cantu, III, MD
Department of Surgery
Duke University Medical Center, Durham, North Carolina

R. Duane Davis, Jr, MD
Department of Surgery
Duke University Medical Center, Durham, North Carolina

Jeffrey D. Edelman, MD
Associate Professor of Medicine
University of Washington Medical Center, Seattle, Washington

Adaani E. Frost, MD
Baylor College of Medicine, Houston, Texas

Agenda

Pulmonary Hypertension and Lung Transplantation, 2010
Adaani E. Frost, MD

Surgical Treatment of Pulmonary Arterial Hypertension
Edward Cantu, III, MD, and R. Duane Davis, Jr, MD

Outcomes, Management, and Complications of Lung Transplantation for Pulmonary Hypertension
Jeffrey D. Edelman, MD

CME Accreditation and Credit Designation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Michigan Medical School and the Pulmonary Hypertension Association. The University of Michigan is accredited by the ACCME to provide continuing medical education to physicians.

The University of Michigan Medical School designates this activity for a maximum of 2.0 AMA PRA Category 1 Credits.™ Physicians should claim credit commensurate with the extent of their participation in the activity.

Completion of this activity involves reading the journal and completing the self-assessment examination and evaluation form, which may take up to 2 hours. Credits for this self-study program are available from December 10, 2010 through December 10, 2011. There is no fee for this program.

Oversight and Accreditation

Arlene Bradford
Assistant Director
Office of CME, University of Michigan Medical School

Disclosures

The Accreditation Council for Continuing Medical Education and the Association of American Colleges have standards and guidelines to ensure that individuals participating in CME activities are aware of relationships between authors and commercial companies that could potentially affect the information presented. To be disclosed to participants are all personal financial relationships with a commercial interest whose products are relevant to the content of this CME activity. The University of Michigan Medical School follows these national policies to ensure balance, independence, objectivity, and scientific rigor in all its CME activities. Each author was asked to complete a disclosure information form for this activity. Disclosures are reported below:

Deborah Jo Levine, MD, and R. Duane Davis, Jr, MD have indicated no relevant financial conflicts to disclose.
Adaani E. Frost, MD, Jeffrey D. Edelman, MD, Edward Cantu, III, MD, Arlene Bradford has no relevant personal financial relationships to disclose.

CME Reviewer

Kevin Chan, MD
Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
University of Michigan Health Systems, Ann Arbor, Michigan

Dr Chan has no relevant personal financial relationships to disclose.

 

Next